France· FR:61695844
TACHOSIL, matrice pour collage tissulaire
A medicinal product containing fibrinogène humain + thrombine humaine, registered in France by CORZA MEDICAL (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FIBRINOGÈNE HUMAIN + THROMBINE HUMAINE
- Manufacturer
- CORZA MEDICAL (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
- cip133400955001256plaquette(s) PET-GAG (polyéthylène téréphtalate - glucosaminoglycane) polyéthylène de 1 éponge(s) pré-enroulée de 4,8 cm x 4,8 cm
- cip133400956580750plaquette(s) PET-GAG (polyéthylène téréphtalate - glucosaminoglycane) polyéthylène de 1 éponge(s) de 9,5 cm x 4,8 cm
- cip133400956580811plaquette(s) PET-GAG (polyéthylène téréphtalate - glucosaminoglycane) polyéthylène de 2 éponge(s) de 4,8 cm x 4,8 cm
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fcc47d29-508a-442d-ab79-15c3b5add416 GET /v1/drugs/fcc47d29-508a-442d-ab79-15c3b5add416?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61695844",
"date_amm": "2004-06-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/04/277",
"substance": "FIBRINOGÈNE HUMAIN + THROMBINE HUMAINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "matrice",
"voies_administration": "intralésionnelle",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about fibrinogène humain + thrombine humaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.